Fumaric Acid

Fumaric Acid

SCHEMBL6558426

CN1C[C@@H]2CC(=O)c3ccc(Cl)cc3[C@@H]2C1.O=C(O)C=CC(=O)O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 known ✓ O00255 4/20 0.42
KMT2A known ✓ Q03164 4/20 0.42
HRH1 known ✓ P35367 2/20 0.38
DRD2 known ✓ P14416 2/20 0.38
DRD1 known ✓ P21728 2/20 0.38
CHRM2 known ✓ P08172 1/20 0.38
HTR1A known ✓ P08908 1/20 0.38
ADRA2A known ✓ P08913 1/20 0.38
ADRA2B known ✓ P18089 1/20 0.38
ADRA2C known ✓ P18825 1/20 0.38
SLC6A2 known ✓ P23975 1/20 0.38
ADRA1D known ✓ P25100 1/20 0.38
HTR2A known ✓ P28223 1/20 0.38
HTR2C known ✓ P28335 1/20 0.38
SLC6A4 known ✓ P31645 1/20 0.38
ADRA1A known ✓ P35348 1/20 0.38
ADRA1B known ✓ P35368 1/20 0.38
HTR2B known ✓ P41595 1/20 0.38
SLC6A3 known ✓ Q01959 1/20 0.38
KCNH2 known ✓ Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL7867766 1.00 HRH2 (0.54) HRH2MEN1KMT2AMAPTLMNA
Fumaric Acid SCHEMBL6558419 1.00 HRH2 (0.54) HRH2MEN1KMT2AMAPTLMNA
Fumaric Acid SCHEMBL6558421 1.00 HRH2 (0.54) HRH2MEN1KMT2AMAPTLMNA
SCHEMBL6558482 0.90 CHRM2 (0.44) HRH2MEN1KMT2AHRH1DRD2
SCHEMBL6558486 0.90 CHRM2 (0.44) HRH2MEN1KMT2AHRH1DRD2
SCHEMBL6558479 0.90 CHRM2 (0.44) HRH2MEN1KMT2AHRH1DRD2
Fumaric Acid SCHEMBL6556542 0.87 HRH2 (0.39) HRH2MEN1KMT2AMAPTLMNA
Fumaric Acid SCHEMBL6556540 0.87 HRH2 (0.39) HRH2MEN1KMT2AMAPTLMNA
Fumaric Acid SCHEMBL6556537 0.87 HRH2 (0.39) HRH2MEN1KMT2AMAPTLMNA
Fumaric Acid SCHEMBL7868829 0.87 HRH2 (0.39) HRH2MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958285-B1 TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES HOFFMANN LA ROCHE (CH) 2004-01-07 EP disclosed
US-6310208-B1 Serotonin receptor binding benzo[e]isoindoles and benzo[h]isoquinolines HOFFMANN-LA ROCHE INC. 2001-10-30 US disclosed
EP-0958285-A1 TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES F.HOFFMANN-LA ROCHE AG (CH) 1999-11-24 EP disclosed
WO-1998030546-A1 TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES F. HOFFMANN-LA ROCHE AG (CH) 1998-07-16 WO disclosed